Las Vegas, NV -- (SBWIRE) -- 10/05/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Eli Lilly & Co. (NYSE:LLY), Idera Pharmaceuticals Inc (NASDAQ:IDRA), Boston Scientific Corporation (NYSE:BSX), Elan Corporation, plc (ADR) (NYSE:ELN)
Eli Lilly & Co. (NYSE:LLY) managed to keep its fall at -0.86% on above-normal volume of 10.75M shares. The stock settled at $48.38 after floating in a range of $48.01 to $48.86. Its latest price has reached market capitalization of $54.51 billion. Its 52-week range has been $44.88 to $58.40. Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide.
Has LLY Found The Bottom and Ready To Move Up? Find Out Here
Idera Pharmaceuticals Inc (NASDAQ:IDRA) traded up on a volume of 10.59 million, higher than its standard daily volume. Shares have gained 16.73% to $2.86. Over the last twelve months, the stock has gained 177.67% and faced a worst price of $0.19. Idera Pharmaceuticals, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (DNA) - and ribonucleic acid (RNA) - based drug candidates.
For How Long IDRA’s Gloss will Attract Investors? Find out via this report
Boston Scientific Corporation (NYSE:BSX) settled 0.26% higher at $11.69 on below -normal volume of 8.98M shares during the last trading day. The stock has its 12-month high at $12.16 and 52-week low price was $5.04. It traded in a range of $11.60 to $11.75 during the last trading day. Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide.
Why Should Investors Buy BSX After the Recent Fall? Just Go Here and Find Out
In the last trading session, Elan Corporation, plc (ADR) (NYSE:ELN) was up on high volume, trading at a volume of 8.94M versus its average daily volume of 6.54 million shares. At $16.04, the stock has attained market capitalization of 8.23 billion. Elan Corporation, plc operates as a biotechnology company in the United States, Ireland, and internationally.
Will ELN Continue To Move Higher? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)